Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study

2018288 citationsJournal Articlehybrid Open Access

Authors

NCT02404350; Results.

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 77, Issue 6, pp. 890-897

Field-Weighted Citation Impact: 29.18